[ Tips ] 一分鐘使用導覽
商品編號： 9-620-021 出版日期： 2019/09/16 作者姓名： Shih, Willy 商品類別： Operations management 商品規格： 25p 再版日期： 地域： Belgium 產業： Biotechnology;Manufacturing;Pharmaceuticals 個案年度： 2016 - 2019
商品敘述：
Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and their critical role in public health made their production an important economic and political issue. This case describes the Foundation''s investment in a breakthrough vaccine manufacturing platform for the Sabin inactivated polio virus. While the new technology promised a much lower cost per dose, it also raised questions about the consequences of lowering entry barriers to vaccine production, as maintaining high quality and production standards, a strong regulatory environment were critical to protecting the integrity of the vaccine supply. The new technology also threatened to encourage more developed country vaccine manufacturers to exit the market, not an outcome the Foundation was hoping for, as they possessed the capabilities and resources to invest in future developments. It raises the question of whether vaccines are a public good, and who should be responsible for their production.
涵蓋領域：
Production;Products;Supply chain management
相關資料：
哪些人也有訂購？